Honokiol modulates invasion and autophagy in pancreatic cancer via the miR-101/QKI axis in cancer-associated fibroblasts

No abstract is available for this paper.

• Publication year

  2025

• Venue

  Journal of Radiation Research and Applied Sciences

• Publication date

  2025-12-01

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1016/j.jrras.2025.102052
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• The function of microRNA related to cancer-associated fibroblasts in pancreatic ductal adenocarcinoma.

  2025cited by this paper
• An alternative splicing signature defines the basal-like phenotype and predicts worse clinical outcome in pancreatic cancer

  2024cited by this paper
• Tumor cell-intrinsic epigenetic dysregulation shapes cancer-associated fibroblasts heterogeneity to metabolically support pancreatic cancer.

  2024cited by this paper
• Metabolic rewiring and communication in cancer immunity

  2024cited by this paper
• Fibroblasts in pancreatic cancer: molecular and clinical perspectives.

  2023cited by this paper
• Gemcitabine and rapamycin-loaded mixed polymeric thermogel for metastatic pancreatic cancer therapy.

  2023cited by this paper
• Mutant KRAS Mediates circARFGEF2 Biogenesis to Promote Lymphatic Metastasis of Pancreatic Ductal Adenocarcinoma

  2023cited by this paper
• Aberrantly Expressed MicroRNAs in Cancer-Associated Fibroblasts and Their Target Oncogenic Signatures in Hepatocellular Carcinoma

  2023cited by this paper
• Honokiol Inhibits HIF-1α-Mediated Glycolysis to Halt Breast Cancer Growth

  2022cited by this paper
• Barriers and opportunities for gemcitabine in pancreatic cancer therapy

  2022cited by this paper
• PEGPH20, a PEGylated human hyaluronidase, induces radiosensitization by reoxygenation in pancreatic cancer xenografts. A molecular imaging study

  2022cited by this paper
• Classical and noncanonical functions of miRNAs in cancers.

  2021cited by this paper
• Honokiol Suppresses Perineural Invasion of Pancreatic Cancer by Inhibiting SMAD2/3 Signaling

  2021cited by this paper
• DIVERSITY AND BIOLOGY OF CANCER-ASSOCIATED FIBROBLASTS.

  2020cited by this paper
• Genome-wide identification of microRNAs and phased siRNAs in soybean roots under long-term salt stress

  2020cited by this paper
• Honokiol Suppressed Pancreatic Cancer Progression via miR-101/Mcl-1 Axis

  2020cited by this paper
• Pancreatic cancer stroma: an update on therapeutic targeting strategies

  2020cited by this paper
• Effects of RNA binding protein QKI on pancreatic cancer ductal epithelial cells and surrounding activation fibroblasts

  2019cited by this paper
• Tumor-stromal crosstalk in pancreatic cancer and tissue fibrosis

  2019cited by this paper
• Autophagy-dependent secretion: mechanism, factors secreted, and disease implications

  2019cited by this paper
• Targeting LIF-mediated paracrine interaction for pancreatic cancer therapy and monitoring

  2019cited by this paper
• Honokiol-enhanced cytotoxic T lymphocyte activity against cholangiocarcinoma cells mediated by dendritic cells pulsed with damage-associated molecular patterns

  2019cited by this paper
• Cancer Statistics for Hispanics/Latinos, 2018

  2018cited by this paper
• The pancreatic cancer microenvironment: A true double agent

  2017cited by this paper
• Cancer-associated fibroblasts promote cancer cell growth through a miR-7-RASSF2-PAR-4 axis in the tumor microenvironment

  2016cited by this paper
• Vascular mimicry formation is promoted by paracrine TGF-β and SDF1 of cancer-associated fibroblasts and inhibited by miR-101 in hepatocellular carcinoma.

  2016cited by this paper
• Honokiol suppresses pancreatic tumor growth, metastasis and desmoplasia by interfering with tumor-stromal cross-talk.

  2016cited by this paper
• Honokiol inhibits sphere formation and xenograft growth of oral cancer side population cells accompanied with JAK/STAT signaling pathway suppression and apoptosis induction

  2016cited by this paper
• Reprogramming of Normal Fibroblasts into Cancer-Associated Fibroblasts by miRNAs-Mediated CCL2/VEGFA Signaling

  2016cited by this paper
• The crosstalk between microRNAs and the Wnt/β-catenin signaling pathway in cancer

  2016cited by this paper
• Multifunctional effects of honokiol as an anti-inflammatory and anti-cancer drug in human oral squamous cancer cells and xenograft.

  2015cited by this paper
• Depletion of Carcinoma-Associated Fibroblasts and Fibrosis Induces Immunosuppression and Accelerates Pancreas Cancer with Reduced Survival.

  2015cited by this paper
• Honokiol inhibits bladder tumor growth by suppressing EZH2/miR-143 axis

  2015cited by this paper
• miR-101 represses lung cancer by inhibiting interaction of fibroblasts and cancer cells by down-regulating CXCL12.

  2015cited by this paper
• Cancer treatment and survivorship statistics, 2014

  2014cited by this paper
• Honokiol inhibits epithelial—mesenchymal transition in breast cancer cells by targeting signal transducer and activator of transcription 3/Zeb1/E‐cadherin axis

  2014cited by this paper
• MiR-21/Smad 7 signaling determines TGF-β1-induced CAF formation

  2013cited by this paper
• Honokiol: a novel natural agent for cancer prevention and therapy.

  2012cited by this paper
• Honokiol Arrests Cell Cycle, Induces Apoptosis, and Potentiates the Cytotoxic Effect of Gemcitabine in Human Pancreatic Cancer Cells

  2011cited by this paper
• Preoperative/Neoadjuvant Therapy in Pancreatic Cancer: A Systematic Review and Meta-analysis of Response and Resection Percentages

  2010cited by this paper
• Origins and Mechanisms of miRNAs and siRNAs.

  2009cited by this paper
• Honokiol, a Multifunctional Antiangiogenic and Antitumor Agent

  2009cited by this paper

• No citing papers are available for this paper.